5' trans-splicing repair of the PLEC1 gene.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Investigative Dermatology

• Publication date

  2008-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/SJ.JID.5701152PMID 17989727
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Using 5'-PTMs to repair mutant beta-globin transcripts.

  2007cited by this paper
• Using 59-PTMs to repair mutant b-globin transcripts

  2007cited by this paper
• KISS: the kinetoplastid RNA editing sequence search tool.

  2006cited by this paper
• RNA repair for haemophilia A

  2006cited by this paper
• 712. High Capacity Screen To Select Optimal Pre-trans-splicing Molecules for Trans-splicing Applications|[ast]|

  2004cited by this paper
• Trans-splicing repair of CD40 ligand deficiency results in naturally regulated correction of a mouse model of hyper-IgM X-linked immunodeficiency

  2004cited by this paper
• Correction of ATM gene function by aminoglycoside-induced read-through of premature termination codons.

  2004cited by this paper
• Development of spliceosome‐mediated RNA trans‐splicing (SMaRT™) for the correction of inherited skin diseases

  2003cited by this paper
• Phenotype correction of hemophilia A mice by spliceosome-mediated RNA trans-splicing

  2003cited by this paper
• 5' exon replacement and repair by spliceosome-mediated RNA trans-splicing.

  2003cited by this paper
• Plectin 5'-transcript diversity: short alternative sequences determine stability of gene products, initiation of translation and subcellular localization of isoforms.

  2003cited by this paper
• Partial correction of endogenous ΔF508 CFTR in human cystic fibrosis airway epithelia by spliceosome-mediated RNA trans-splicing

  2002cited by this paper
• A compound heterozygous one amino-acid insertion/nonsense mutation in the plectin gene causes epidermolysis bullosa simplex with plectin deficiency.

  2001cited by this paper
• Spliceosome-mediated RNA trans-splicing as a tool for gene therapy

  1999cited by this paper
• A panel of monoclonal antibodies to rat plectin: distinction by epitope mapping and immunoreactivity with different tissues and cell lines.

  1994cited by this paper
• Improved Retroviral Vectors for Gene Transfer and Expression

  1989cited by this paper
• Improved retroviral vectors for gene transfer and expression.

  1989cited by this paper

• RNA exon editing: Splicing the way to treat human diseases

  2024cites this paper
• Emerging DNA & RNA editing strategies for the treatment of epidermolysis bullosa

  2024cites this paper
• Gene-edited cells: novel allogeneic gene/cell therapy for epidermolysis bullosa

  2024cites this paper
• Plectin deficiency in fibroblasts deranges intermediate filament and organelle morphology, migration, and adhesion.

  2023cites this paper
• COL7A1 Editing via RNA Trans-Splicing in RDEB-Derived Skin Equivalents

  2023cites this paper
• Current developments in gene therapy for epidermolysis bullosa

  2022cites this paper
• Integrated Management Strategies for Epidermolysis Bullosa: Current Insights

  2022cites this paper
• 5′RNA Trans-Splicing Repair of COL7A1 Mutant Transcripts in Epidermolysis Bullosa

  2022cites this paper
• Evaluating a Targeted Cancer Therapy Approach Mediated by RNA trans-Splicing In Vitro and in a Xenograft Model for Epidermolysis Bullosa-Associated Skin Cancer

  2022cites this paper
• Challenges in Treating Genodermatoses: New Therapies at the Horizon

  2022influential citation
• Therapy Development for Epidermolysis Bullosa

  2021cites this paper
• Plectin in Skin Fragility Disorders

  2021cites this paper
• Investigational Treatments for Epidermolysis Bullosa

  2021cites this paper
• Clinical Perspectives of Gene-Targeted Therapies for Epidermolysis Bullosa

  2021cites this paper
• Dominant pretibial dystrophic epidermolysis bullosa in an Italian family

  2020cites this paper
• Therapeutic applications of trans-splicing.

  2020cites this paper
• Invited Review Therapeutic applications of trans -splicing

  2020cites this paper
• CRISPR/Cas9 gene editing for genodermatoses: progress and perspectives.

  2019cites this paper
• Epidermolysis bullosa: Advances in research and treatment

  2019cites this paper
• Cancer-type organic anion transporting polypeptide 1B3 is a target for cancer suicide gene therapy using RNA trans-splicing technology.

  2018cites this paper
• RNA Trans-Splicing Modulation via Antisense Molecule Interference

  2018cites this paper
• Advances on potential therapeutic options for epidermolysis bullosa

  2018cites this paper
• Methods of Gene Therapy for Treatment of Inherited Epidermolysis Bullosa

  2018cites this paper
• An ex vivo RNA trans‐splicing strategy to correct human generalized severe epidermolysis bullosa simplex

  2018cites this paper
• Optimization of trans-Splicing for Huntington's Disease RNA Therapy

  2017cites this paper
• 13 High-Throughput Screening for Highly Functional RNA-Trans-Splicing Molecules : Correction of Plectin in Epidermolysis Bullosa Simplex

  2017cites this paper
• RNA‐based therapies for genodermatoses

  2017cites this paper
• Functional therapies for cutaneous wound repair in epidermolysis bullosa

  2017cites this paper
• Gene Therapy for Inherited Skin Disorders

  2017cites this paper
• Designing Efficient Double RNA trans-Splicing Molecules for Targeted RNA Repair

  2016cites this paper
• mRNA trans‐splicing in gene therapy for genetic diseases

  2016cites this paper
• A Gene Gun-mediated Nonviral RNA trans-splicing Strategy for Col7a1 Repair.

  2016cites this paper
• Keratins and Their Role in EB Simplex

  2015cites this paper
• Trans-Splicing Improvement by the Combined Application of Antisense Strategies

  2015cites this paper
• Gene Therapy via Trans-Splicing for LMNA-Related Congenital Muscular Dystrophy

  2015cites this paper
• Plectin-related skin diseases.

  2015cites this paper
• CD22ΔE12 as a molecular target for corrective repair using RNA trans-splicing: anti-leukemic activity of a rationally designed RNA trans-splicing molecule.

  2015cites this paper
• Therapies for inherited skin fragility disorders

  2015cites this paper
• Design and Characterization of a Twin Ribozyme for Potential Repair of a Deletion Mutation within the Oncogenic CTNNB1‐ΔS45 mRNA

  2014cites this paper
• Current and Novel Approaches for Genetic Skin Disorders

  2014cites this paper
• Inherited blistering skin diseases: underlying molecular mechanisms and emerging therapies

  2014cites this paper
• ESSAI DU TRIMÉTHYLAMINE N-OXYDE ET DU SODIUM 4-PHÉNYLBUTYRATE, CHAPERONNES À POTENTIEL THÉRAPEUTIQUE, DANS L'ÉPIDERMOLYSE BULLEUSE SIMPLEX CAUSÉE PAR UNE MUTATION DANS LA KÉRATINE 14

  2014cites this paper
• Redesign of trans-splicing molecules for the correction of dystrophia myotonica type 1 toxic RNA transcripts

  2014cites this paper
• Molecular therapies for epidermolysis bullosa.

  2013cites this paper
• Repair of Mybpc3 mRNA by 5′-trans-splicing in a Mouse Model of Hypertrophic Cardiomyopathy

  2013cites this paper
• A Reporter-Based Screen to Identify Potent 3’ Trans-Splicing Molecules for Endogenous RNA Repair

  2013cites this paper
• Gene Therapy for the COL 7 A 1 Gene

  2013cites this paper
• Gene Therapy for the COL7A1 Gene

  2013cites this paper
• The long and winding road that leads to a cure for epidermolysis bullosa.

  2013cites this paper
• RNA trans-splicing for genodermatoses.

  2013cites this paper
• Progress towards genetic and pharmacological therapies for keratin genodermatoses: current perspective and future promise

  2012cites this paper
• Replacement of huntingtin exon 1 by trans-splicing

  2012cites this paper
• Spliceosome-mediated trans-splicing: the therapeutic cut and paste.

  2012cites this paper
• Gene therapy of skin adhesion disorders (mini review).

  2012cites this paper
• Transcutaneous gene gun delivery of hNC16A Induces BPAG2-specific tolerance.

  2012cites this paper
• Spliceosome-Mediated RNA Trans-Splicing Facilitates Targeted Delivery of Suicide Genes to Cancer Cells

  2011cites this paper
• Functional correction of type VII collagen expression in dystrophic epidermolysis bullosa.

  2011cites this paper
• Skin Gene and Cell Therapy

  2011cites this paper
• High-Throughput Screening for Highly Functional RNA-Trans-Splicing Molecules: Correction of Plectin in Epidermolysis Bullosa Simplex

  2011influential citation
• Human Genetic Diseases

  2011cites this paper
• Defining keratin protein function in skin epithelia: Epidermolysis Bullosa Simplex and its aftermath

  2011cites this paper
• Overcoming obstacles for gene therapy for recessive dystrophic epidermolysis bullosa.

  2011cites this paper
• A novel screening system improves genetic correction by internal exon replacement

  2011cites this paper
• The falsifiability of the models for the origin of eukaryotes

  2011cites this paper
• K14 mRNA reprogramming for dominant epidermolysis bullosa simplex.

  2010cites this paper
• The vesiculobullous reaction pattern

  2010cites this paper
• Trans-Splicing-Mediated Improvement in a Severe Mouse Model of Spinal Muscular Atrophy

  2010cites this paper
• Correction of dystrophia myotonica type 1 pre-mRNA transcripts by artificial trans-splicing

  2009cites this paper
• Correction of tau mis-splicing caused by FTDP-17 MAPT mutations by spliceosome-mediated RNA trans-splicing

  2009cites this paper
• McMillanJR,LongHA,AkiyamaM,ShimizuH&KimbleRM

  2009cites this paper
• Current advances in gene therapy for the treatment of genodermatoses.

  2009cites this paper
• Molécules trans-splicing pre-mARN améliorées et leurs utilisations

  2008cites this paper
• SMaRT technology enables gene expression repair in skin gene therapy.

  2008cites this paper
• Development of a Single Vector System that Enhances Trans-Splicing of SMN2 Transcripts

  2008cites this paper
• Verbesserte Prä-mRNA-Trans-Splicing-Moleküle und deren Verwendungen

  2008cites this paper